Inactivation of cytochrome P450S 2B1, 2B4, 2B6, and 2B11 by arylalkynes

Drug Metabolism and Disposition

Volumn 25, Issue 11, 1997, Pages 1242-1248

  Roberts, Elizabeth S ^a   Hopkins, Nancy Eddy ^a   Foroozesh, Maryam ^a   Alworth, William L ^a   Halpert, James R ^a   Hollenberg, Paul F ^a  

^a Med Science Research Building III ^*

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON; CYTOCHROME P450; ERYTHROMYCIN; ETHOXYRESORUFIN DEETHYLASE; LIDOCAINE; NITROPHENOL; OXYGENASE; PENTOXYRESORUFIN; PHENOBARBITAL; PYRIDINE; TESTOSTERONE;

ARTICLE; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INDUCTION; ENZYME KINETICS; ENZYME SPECIFICITY; PRIORITY JOURNAL;

ALKYNES; ANESTHETICS, LOCAL; ANIMALS; ANTI-BACTERIAL AGENTS; AUTORADIOGRAPHY; CYTOCHROME P-450 ENZYME SYSTEM; DOGS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; ERYTHROMYCIN; FEMALE; HUMANS; LIDOCAINE; MALE; MICE; MICROSOMES, LIVER; NITROPHENOLS; RABBITS; RATS; RATS, INBRED F344; TESTOSTERONE;

CANIS FAMILIARIS; LANES; ORYCTOLAGUS CUNICULUS;

EID: 0030720486     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. D. R. Nelson, L. Koymans, T. Kamataki, J. J. Stegeman, R. Feyereisen, D. J. Waxman, M. R. Waterman, O. Gotoh, M. J. Coon, R. W. Estabrook, I. C. Gunsalus, and D. W. Nebert: P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6, 1-42 (1996).
2. P. R. Ortiz de Montellano, and K. L. Kunze: Self-catalyzed inactivation of hepatic cytochrome P-450 by ethynyl substrates. J. Biol. Chem. 255, 5578-5585 (1980).
3. 3H]-labeled 2-ethynylnaphthalene-inactivated P450 2B1 and 2B4 using amino acid sequencing and mass spectrometry. Biochemistry 33, 3766-3771 (1994).
4. G. J. Hammons, W. L. Alworth, N. E. Hopkins, F. P. Guengerich, and F. F. Kadlubar: 2-Ethynylnaphthalene as a mechanism-based inactivator of the cytochrome P450 catalyzed N-oxidation of 2-naphthylamine. Chem. Res. Toxicol. 2, 367-374 (1989).
5. C. H. Yun, G. J. Hammons, G. Jones, M. V. Martin, N. E. Hopkins, W. L. Alworth, and F. P. Guengerich: Modification of cytochrome P450 1A2 enzymes by the mechanism-based inactivator 2-ethynylnaphthalene and the photoaffinity label 4-azidobiphenyl. Biochemistry 31, 10556-10563 (1992).
6. M. Foroozesh, G. Primrose, Z. Guo, L. C. Bell, W. L. Alworth, and F. P. Guengerich: Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes. Chem. Res. Toxicol. 10, 91-102 (1997).
7. L. E. Beebe, E. S. Roberts, L. W. Fornwald, P. F. Hollenberg, and W. L. Alworth: Mechanism-based inhibition of mouse P450 2b-10 by selected arylalkynes. Biochem. Pharmacol. 52, 1507-1513 (1996).
8. N. E. Hopkins, M. K. Foroozesh, and W. L. Alworth: Suicide inhibitors of cytochrome P450 1A1 and P450 2B1. Biochem. Pharmacol. 44, 787-796 (1992).
9. Y. Oda, S. Imaoka, Y. Nakahira, A. Asada, M. Fujimori, S. Fujita, and Y. Funae: Metabolism of lidocaine by purified rat liver microsomal cytochrome P-450 isozymes. Biochem. Pharmacol. 38, 4439-4444 (1989).
10. T. Saito, and H. W. Strobel: Purification to homogeneity and characterization of a form of cytochrome P450 with high specificity for benzo[a]pyrene from β-naphthoflavone-pretreated rat liver microsomes. J. Biol. Chem. 256, 984-988 (1981).
11. H. W. Strobel, and J. D. Dignam: Purification and properties of NADPH-cytochrome P-450 reductase. Methods Enzymol. 52, 89-96 (1978).
12. M. J. Coon, T. A. van der Hoeven, S. B. Dahl, and D. A. Haugen: Two forms of liver microsomal cytochrome P450, P450 LM2 and P450 LM4 (rabbit liver). Methods Enzymol. 52, 109-117 (1978).
13. D. B. Duignan, I. G. Sipes, T. B. Leonard, and J. R. Halpert: Purification and characterization of the dog hepatic cytochrome P-450 isozyme responsible for the metabolism of 2,4,5,2′,4′,5′-hexachlorobiphenyl. Arch. Biochem. Biophys. 255, 290-303 (1987).
14. E. S. Roberts, N. E. Hopkins, E. J. Zaluzec, D. A. Gage, W. L. Alworth, and P. F. Hollenberg: Mechanism-based inactivation of cytochrome P450 2B1 by 9-ethynylphenanthrene. Arch. Biochem. Biophys. 323, 295-302 (1995).
15. J. T. M. Buters, C. D. Schiller, and R. C. Chou: A highly sensitive tool for the assay of cytochrome P450 enzyme activity in rat, dog, and man: direct fluorescence of the deethylation of 7-ethoxy-4-trifluoromethylcoumarin. Biochem. Pharmacol. 46, 1577-1584 (1993).
16. W. F. Greenlee, and A. Poland: An improved assay of 7-ethoxycoumarin O-deethylase activity: induction of hepatic enzyme activity in C57BL/6J and DBA/2J mice by phenobarbital, 3-methylcholanthrene, and 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Pharmacol. Exp. Ther. 205, 596-605 (1978).
17. 19 steroids by 5 highly purified and reconstituted rat hepatic cytochrome P-450 isozymes. J. Biol. Chem. 258, 8839-8847 (1983).
18. A. J. Sonderfan, M. P. Arlotto, D. R. Dutton, S. K. McMillen, and A. Parkinson: Regulation of testosterone hydroxylation by rat liver microsomal cytochrome P-450. Arch. Biochem. Biophys. 255, 27-41 (1987).
19. U. K. Laemmli: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.) 277, 680-685 (1970).
20. M. Shou, K. R. Korzekwa, K. W. Krausz, C. L. Crespi, F. J. Gonzalez, and H. V. Gelboin: Regio-and stereo-selective metabolism of phenanthrene by twelve cDNA-expressed human, rodent, and rabbit cytochromes P-450. Cancer Lett. 83, 305-313 (1994).
21. Y. Suwa, Y. Mizukami, K. Sogawa, and Y. Fujii-Kuriyama: Gene structure of a major form of phenobarbital-inducible cytochrome P-450 in rat liver. J. Biol. Chem. 260, 7980-7984 (1985).
22. G. E. Tarr, S. D. Black, V. S. Fujita, and M. J. Coon: Complete amino acid sequence and predicted membrane topology of phenobarbital-induced cytochrome P-450 (isozyme 2) from rabbit liver microsomes. Proc. Natl. Acad. Sci. USA 80, 6552-6556 (1983).
23. S. Yamano, P. T. Nhamburo, T. Aoyama, U. A. Meyer, T. Inaba, W. Kalow, H. V. Gelboin, O. W. McBride, and F. J. Gonzalez: cDNA cloning and sequence and cDNA-directed expression of human P450 HB1: identification of a normal and two variant cDNAs derived from the CYP2B locus on chromosome 19 and differential expression of the IIB mRNAs in human liver. Biochemistry 28, 7340-7348 (1989).
24. 16α) of testosterone 16α-hydroxylase in mouse liver, chromosome localization, and cloning of P-450 cDNA. Biochemistry 27, 6434-6443 (1988).
25. P. E. Graves, G. A. Elhag, P. J. Ciaccio, D. P. Bourque, and J. R. Halpert: cDNA and deduced amino acid sequences of a dog hepatic cytochrome P450IIB responsible for the metabolism of 2,2′,4,4′,5,5′-hexachlorobiphenyl. Arch. Biochem. Biophys. 281, 106-115 (1990).
26. P. Soucek, and I. Gut: Cytochromes P-450 in rats: structures, functions, properties and relevant human forms. Xenobiotica 22, 83-103 (1992).
27. B. A. Swanson, J. R. Halpert, L. M. Bornheim, and P. R. Ortiz de Montellano: Topological analysis of the active sites of cytochromes P450IIB4 (rabbit), P450 IIB10 (mouse), and P450 IIB11 (dog) by in situ rearrangement of phenyl-iron complexes. Arch. Biochem. Biophys. 292, 42-46 (1992).
28. B. A. Swanson, D. R. Dutton, J. M. Lunetta, C. S. Yang, and P. R. Ortiz de Montellano: The active sites of cytochromes P450 1A1, IIB1, IIB2, and IIE1. J. Biol. Chem. 266, 19258-19264 (1991).
29. D. J. Newton, R. W. Wang, and A. Y. Lu: Cytochrome P450 inhibitors: evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metab. Dispos. 23, 154-158 (1995).